MAVRIC VR ICD Registry

NCT00270933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 742

Last updated 2023-12-21

No results posted yet for this study

Summary

The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.

Conditions

  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

Registry

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • George Klein, M.D. · London H.S.C. University Campus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2005-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00270933 on ClinicalTrials.gov